UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review with meta‐analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations

Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (3), p.266-276

2022

Volltextzugriff (PDF)

Letter: Chinese herbal medicine Curcumin–QingDai (CurQD)—A good treatment option for active ulcerative colitis? Authors' reply

Alimentary pharmacology & therapeutics, 2023-09, Vol.58 (6), p.641-641

2023

Volltextzugriff (PDF)

Letter: loss of response to anti‐TNFα agents in patients with inflammatory bowel disease depends on treatment duration

Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (4), p.497-498

2022

Volltextzugriff (PDF)

Editorial: tofacitinib post‐marketing safety reports among ulcerative colitis patients

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.131-132

2022

Volltextzugriff (PDF)

Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti‐TNF?

Alimentary pharmacology & therapeutics, 2020-06, Vol.51 (11), p.1198-1199

2020

Volltextzugriff (PDF)

Editorial: biomarker predictors of non‐response to TNFα antagonists—the quest continues

Alimentary pharmacology & therapeutics, 2019-04, Vol.49 (8), p.1089-1090

2019

Volltextzugriff (PDF)

Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study

Alimentary pharmacology & therapeutics, 2022-08, Vol.56 (3), p.463-476

2022

Volltextzugriff (PDF)

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Alimentary pharmacology & therapeutics, 2020-07, Vol.52 (1), p.135-142

2020

Volltextzugriff (PDF)

Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study

Alimentary pharmacology & therapeutics, 2023-07, Vol.58 (2), p.175-181

2023

Volltextzugriff (PDF)

Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease

Inflammatory bowel diseases, 2020-10, Vol.26 (10), p.1619-1625

2020

Volltextzugriff (PDF)

The role of multimodal treatment in Crohn′s disease patients with perianal fistula: a multicentre retrospective cohort study

Alimentary pharmacology & therapeutics, 2018-11, Vol.48 (9), p.941-950

2018

Volltextzugriff (PDF)

Prediction of patency capsule retention in known Crohn's disease patients by using magnetic resonance imaging

Gastrointestinal endoscopy, 2016-01, Vol.83 (1), p.182-187

2016

Volltextzugriff (PDF)

Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence

Gut and Liver, 2023, 17(4), , pp.516-528

2023

Volltextzugriff (PDF)

Tailoring anti-TNF therapy in IBD: drug levels and disease activity

Nature reviews. Gastroenterology & hepatology, 2014-04, Vol.11 (4), p.243-255

2014

Volltextzugriff (PDF)

Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF⁻/⁻ mice

Proceedings of the National Academy of Sciences - PNAS, 2014-04, Vol.111 (13), p.4964-4969

2014

Volltextzugriff (PDF)

A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease

United European gastroenterology journal, 2020-06, Vol.8 (5), p.544-551

2020

Volltextzugriff (PDF)

Impact of COVID‐19 outbreak on the care of patients with inflammatory bowel disease: A comparison before and after the outbreak in South China

Journal of gastroenterology and hepatology, 2021-03, Vol.36 (3), p.700-709

2021

Volltextzugriff (PDF)

Editorial: Finger in the dam-A clinical trial of long-acting somatostatin for high-output ostomies and fistulas

Alimentary pharmacology & therapeutics, 2024-09, Vol.60 (7), p.959-960

2024

Volltextzugriff (PDF)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis

Therapeutic advances in gastroenterology, 2018-01, Vol.11, p.1756284818785571-1756284818785571

2018

Volltextzugriff (PDF)

Change in bowel habits during menstruation: are IBD patients different?

Therapeutic advances in gastroenterology, 2020, Vol.13, p.1756284820929806-1756284820929806

2020

Volltextzugriff (PDF)

Optimizing anti-TNF treatments in inflammatory bowel disease

Autoimmunity reviews, 2014-01, Vol.13 (1), p.24-30

2014

Volltextzugriff (PDF)

Low 6‐thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease

Journal of gastroenterology and hepatology, 2019-04, Vol.34 (4), p.679-685

2019

Volltextzugriff (PDF)

Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort

Therapeutic advances in gastroenterology, 2020, Vol.13, p.1756284820913210-1756284820913210

2020

Volltextzugriff (PDF)

Adalimumab Level in Breast Milk of a Nursing Mother

Clinical gastroenterology and hepatology, 2010-05, Vol.8 (5), p.475-476

2010

Volltextzugriff (PDF)

Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231188587-17562848231188587

2023

Volltextzugriff (PDF)

1 – 25 von 443

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(428)
Mit Volltextzugriff
(407)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(275)
Life Sciences & Biomedicine
(273)
Gastroenterology & Hepatology
(216)
Humans
(191)
Female
(108)
Adult
(102)
Male
(102)
Crohn's Disease
(81)
Inflammatory Bowel Disease
(81)
Middle Aged
(68)
Gastroenterology And Hepatology
(58)
Ulcerative Colitis
(58)
Gastroenterology
(51)
Retrospective Studies
(51)
Young Adult
(50)
Crohn Disease - Drug Therapy
(43)
Inflammatory Bowel Diseases - Drug Therapy
(43)
Infliximab
(40)
Treatment Outcome
(39)
Crohn’s Disease
(35)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Systematic review with meta‐analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations

Letter: Chinese herbal medicine Curcumin–QingDai (CurQD)—A good treatment option for active ulcerative colitis? Authors' reply

Letter: loss of response to anti‐TNFα agents in patients with inflammatory bowel disease depends on treatment duration

Editorial: tofacitinib post‐marketing safety reports among ulcerative colitis patients

Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti‐TNF?

Editorial: biomarker predictors of non‐response to TNFα antagonists—the quest continues

Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study

Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease

The role of multimodal treatment in Crohn′s disease patients with perianal fistula: a multicentre retrospective cohort study

Prediction of patency capsule retention in known Crohn's disease patients by using magnetic resonance imaging

Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence

Tailoring anti-TNF therapy in IBD: drug levels and disease activity

Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF⁻/⁻ mice

A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease

Impact of COVID‐19 outbreak on the care of patients with inflammatory bowel disease: A comparison before and after the outbreak in South China

Editorial: Finger in the dam-A clinical trial of long-acting somatostatin for high-output ostomies and fistulas

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis

Change in bowel habits during menstruation: are IBD patients different?

Optimizing anti-TNF treatments in inflammatory bowel disease

Low 6‐thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease

Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort

Adalimumab Level in Breast Milk of a Nursing Mother

Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease

Suchergebnisse filtern